House Misses Bipartisan Opportunity To Hold Big Pharma Accountable, Increase Transparency For Patients Campaign for Sustainable Rx Pricing Communications Director Lauren Blair issued the following statement in response to Joint House and Senate Conference Committee meeting on H.R. 6157, which now excludes a bipartisan, CSRxP-supported policy – included in the Trump Administration’s blueprint, introduced by Senators Chuck Grassley (R-IA) and […]
Weekly Update – 5/8/2015 We learned this week that worldwide spending on cancer medicines reached $100 billion in 2014, an increase of 10.3 percent from 2013. And let’s not forget about last week’s multiple sclerosis study noting that there has been an “alarming rise” in the cost of these drugs, coming in between $50,000 and […]